HOME >> BIOLOGY >> NEWS
Antiretroviral resistance testing in HIV infected patients improves health and saves costs

During HIV treatment resistance mutations of the virus to antiretroviral drugs may occur and the treatment regimen become less effective. In the present study the authors compared the cost-effectiveness of genotypic antiretroviral resistance testing versus expert opinion for treatment optimization in HIV infected patients with treatment failure. The study is based on data from the Swiss HIV Cohort Study (www.shcs.ch), which is one of the largest cohort studies on HIV disease including patients from all University Clinics and two state hospitals in Switzerland. In this study, both health care costs and productivity costs, i.e. costs due to absence from work because of ill-health, were included in the analysis. Using most recent scientific methods, the authors could show that antiretroviral resistance testing not only increases life expectancy and quality-of-life, but also results in cost savings to society.

"This is the first study that shows that resistance testing not only improves the health of the patients but is also beneficial to the society at large when job productivity changes are considered," said Pedram Sendi, first author and principal investigator, from the Clinic of Infectious Diseases & Hospital Epidemiology of the Basel University Hospital. "We are convinced that our study will be noticed in many countries as it also documents the clinical benefit of antiretroviral resistance testing," comment Manuel Battegay from the Basel University Hospital and Huldrych Gnthard from the Zurich University Hospital, co-principals of this cost-effectiveness study.

In times of increasing pressures to contain health care costs cost-effectiveness analyses are an important source of information to evaluate whether health interventions represent "value for money." This may help to prioritize resource allocation in health care by finding those health technologies that offer the most health outcomes for the resources
'"/>

Contact: Pedram Sendi
pedram.sendi@unibas.ch
41-078-691-8181
Public Library of Science
23-Jan-2007


Page: 1 2

Related biology news :

1. Support for chromosomal theory of cancer found in cancers development of drug resistance
2. 454 sequencing identifies HIV drug resistance at early stage
3. Ultra deep sequencing identifies HIV drug resistance at early stage
4. Cytokine resistance contributes to pathology of type 2 diabetes
5. Largest synthetic gene ever built offers insights into anti-malarial drug resistance
6. WHO data confirms low level of resistance to Tamiflu
7. Unstable leukemia stem cells may predispose patients to drug resistance
8. Gene profiling predicts resistance to breast cancer drug Herceptin
9. IDIBAPS participates in European Network on antibiotic resistances and hospital infections
10. What recognizes what in plant disease resistance?
11. New HIV test may predict drug resistance

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/8/2019)... ... October 08, 2019 , ... ... the National Research Council of Canada (NRC) to create the Laboratory of ... technologies and in manufacturing, LIFT will offer a competitive capacity to accelerate ...
(Date:10/4/2019)... NEW YORK (PRWEB) , ... October 03, 2019 , ... ... the genome that cells hand down from one generation to the next. In a ... mutations can modulate the activity of this enzyme, leading to cancers and other diseases. ...
(Date:9/30/2019)... , ... September 30, 2019 , ... ... focused on increasing the capacity of life science organizations to accelerate innovation and ... Francisco, CA on October 4th. , What: Just 30 days to 21 CFR ...
Breaking Biology News(10 mins):
(Date:10/8/2019)... MELBOURNE, Fla. (PRWEB) , ... October 07, 2019 ... ... and development of low level laser therapy technology (“3LT®”), today announces that the ... to market its EVRL low level laser for the temporary relief of chronic ...
(Date:10/3/2019)... ... October 01, 2019 , ... ... and reset itself, announced the midway point of its randomized research trial for ... study is to measure the efficacy of a non-invasive technology which compares tones ...
(Date:10/3/2019)... ... October 02, 2019 , ... Today marked the official ... enabling clinical program outsourcing success by cultivating radical improvements in leadership, staff, and ... executive Brenda Reese, phaseUP™ brings clients deep, broad and unique expertise in the ...
(Date:10/3/2019)... FAIRFAX, Va. (PRWEB) , ... October 02, 2019 , ... ... the prestigious NHS Digital Health Accelerator run by the East Midlands Academic Health Science ... up the adoption of technology in NHS by providing support to develop and deploy ...
Breaking Biology Technology:
Cached News: